FDA Approved: CARGLUMIC ACID — Supplemental Application (Eton Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for carglumic acid submitted by Eton Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperammonemia
• N-acetylglutamate Synthase Deficiency

Drugs mentioned

• CARGLUMIC ACID (carglumic acid)

Snippet

SUPPL AP for CARGLUMIC ACID (CARGLUMIC ACID)